SignalCorporate
Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and
19.7% CAGR with revenue tripling to $15.3B by 2030 drives market significance.
What changed
19.7% CAGR with revenue tripling to $15.3B by 2030 drives market significance.
Why it matters
19.7% CAGR with revenue tripling to $15.3B by 2030 drives market significance. — impact context not separately stored; see What changed.